Burden of stroke in China: A decomposition analysis investigating the driven factors. [PDF]
Fu L, Jiang W, Peng Y, Zhang X, Zhou R.
europepmc +1 more source
Five‐Year Disease Progression in Synuclein Seeding Positive Sporadic Parkinson's Disease
ABSTRACT Objective To provide a comprehensive description of disease progression in synuclein seeding assay (SAA) positive sporadic Parkinson Disease participants, using Neuronal Synuclein Disease integrated biological and functional impairment staging framework.
Paulina Gonzalez‐Latapi +19 more
wiley +1 more source
2D-JCOG: Transforming 1D <sup>1</sup>H NMR Spectra into J-δ Correlation Maps via the Shared Splitting Theorem and Graph Neural Networks. [PDF]
Cobas C.
europepmc +1 more source
Developmental and Epileptic Encephalopathy due to Biallelic Pathogenic Variants in PIGM
ABSTRACT Objective PIGM encodes a critical enzyme in the glycosylphosphatidylinositol (GPI)‐anchor biosynthesis pathway. While promoter‐region mutations in PIGM have been associated with a relatively mild phenotype characterized by portal vein thrombosis and absence seizures, recent evidence suggests that coding‐region mutations result in a more severe
Júlia Sala‐Coromina +11 more
wiley +1 more source
Learning to share nicely: Leveraging the Nobel Prize-winning Shapley value to enhance collaboration and cooperation in healthcare systems. [PDF]
Mohammed MA, Walton N, Mohammed O.
europepmc +1 more source
ABSTRACT Objectives Retrograde trans‐synaptic degeneration (rTSD) from posterior visual pathway lesions in multiple sclerosis (MS) is characterized by hemi‐macular ganglion cell‐inner plexiform layer (GCIPL) thinning and contralateral visual field loss.
Abdul Jaber Tayem +17 more
wiley +1 more source
Telehealth and the work behavior of mental health clinicians. [PDF]
Song S, Pizer SD, Yee CA.
europepmc +1 more source
ABSTRACT Objective Onasemnogene abeparvovec (OA) is an AAV9‐based gene therapy for spinal muscular atrophy type I (SMA I). Real‐world outcomes show increased response variability compared to clinical trials, and follow‐up data beyond 12–18 months are limited.
Marika Pane +43 more
wiley +1 more source
China's Pharmaceutical Ascent: Opportunity for Global Health, Test for US Leadership. [PDF]
Babul A, Mahdavi P, Hussain M, Babul N.
europepmc +1 more source
Text-guided few-shot liver and tumor segmentation. [PDF]
Chen H +5 more
europepmc +1 more source

